http://new.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 06 Mar 2026 17:52:00 +0000 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://new.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+LANGE+LOUIS+G/26126915.html si-local-file:///var/storage/secattach/20260306/26126915.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+LANGE+LOUIS+G/26126915.html Fri, 06 Mar 2026 17:52:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+LANGE+LOUIS+G/26126915.html si-local-file:///var/storage/secattach/20260306/26126915.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+LANGE+LOUIS+G/26126915.html Fri, 06 Mar 2026 17:52:00 +0000 NAMS O.54602084 http://www.streetinsider.com/Press+Releases/NewAmsterdam+Pharma+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125205.html <p>NAARDEN, the Netherlands and MIAMI, March 06, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 10,000 of NewAmsterdam’s ordinary shares to two non-executive new hires. The share options were granted as an inducement material to the http://www.streetinsider.com/Press+Releases/NewAmsterdam+Pharma+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125205.html Fri, 06 Mar 2026 16:01:00 +0000 NAMS http://www.streetinsider.com/Globe+Newswire/NewAmsterdam+Pharma+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125205.html <p>NAARDEN, the Netherlands and MIAMI, March 06, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“CVD”) with elevated low-density lipoprotein cholesterol (“LDL-C”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced that the Compensation Committee of NewAmsterdam’s Board of Directors approved the grant of inducement share options covering an aggregate of 10,000 of NewAmsterdam’s ordinary shares to two non-executive new hires. The share options were granted as an inducement material to the http://www.streetinsider.com/Globe+Newswire/NewAmsterdam+Pharma+Reports+Inducement+Grants+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26125205.html Fri, 06 Mar 2026 16:01:00 +0000 NAMS http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Kastelein+Johannes+Jacob+Pieter/26119062.html si-local-file:///var/storage/secattach/20260305/26119062.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Kastelein+Johannes+Jacob+Pieter/26119062.html Thu, 05 Mar 2026 16:14:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Kastelein+Johannes+Jacob+Pieter/26119062.html si-local-file:///var/storage/secattach/20260305/26119062.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Kastelein+Johannes+Jacob+Pieter/26119062.html Thu, 05 Mar 2026 16:14:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02++Filed+by%3A+Davidson+Michael+H./26094313.html si-local-file:///var/storage/secattach/20260302/26094313.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02++Filed+by%3A+Davidson+Michael+H./26094313.html Mon, 02 Mar 2026 18:08:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02++Filed+by%3A+Davidson+Michael+H./26094313.html si-local-file:///var/storage/secattach/20260302/26094313.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02++Filed+by%3A+Davidson+Michael+H./26094313.html Mon, 02 Mar 2026 18:08:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Davidson+Michael+H./26092137.html si-local-file:///var/storage/secattach/20260302/26092137.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Davidson+Michael+H./26092137.html Mon, 02 Mar 2026 16:10:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Davidson+Michael+H./26092137.html si-local-file:///var/storage/secattach/20260302/26092137.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++NewAmsterdam+Pharma+Co+++++++++++++++++Filed+by%3A+Davidson+Michael+H./26092137.html Mon, 02 Mar 2026 16:10:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02/26087376.html si-local-file:///var/storage/secattach/20260302/26087376.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02/26087376.html Mon, 02 Mar 2026 08:01:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02/26087376.html si-local-file:///var/storage/secattach/20260302/26087376.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++NewAmsterdam+Pharma+Co++++For%3A+Mar+02/26087376.html Mon, 02 Mar 2026 08:01:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Feb+24++Filed+by%3A+Davidson+Michael+H./26073762.html si-local-file:///var/storage/secattach/20260226/26073762.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Feb+24++Filed+by%3A+Davidson+Michael+H./26073762.html Thu, 26 Feb 2026 21:41:00 +0000 NAMS O.54602084 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Feb+24++Filed+by%3A+Davidson+Michael+H./26073762.html si-local-file:///var/storage/secattach/20260226/26073762.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++NewAmsterdam+Pharma+Co++++For%3A+Feb+24++Filed+by%3A+Davidson+Michael+H./26073762.html Thu, 26 Feb 2026 21:41:00 +0000 NAMS O.54602084